{"id":153046,"date":"2025-06-05T04:09:09","date_gmt":"2025-06-05T04:09:09","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/153046\/"},"modified":"2025-06-05T04:09:09","modified_gmt":"2025-06-05T04:09:09","slug":"adapter-limmunotherapie-a-la-vie-des-malades-peut-la-rendre-plus-efficace","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/153046\/","title":{"rendered":"adapter l\u2019immunoth\u00e9rapie \u00e0 la vie des malades peut la rendre plus efficace"},"content":{"rendered":"

D\u00c9CRYPTAGE – <\/strong>De nombreuses \u00e9tudes pr\u00e9sent\u00e9es lors du congr\u00e8s de canc\u00e9rologie de Chicago ont mis en avant l\u2019int\u00e9r\u00eat de r\u00e9duire les doses et d\u2019adapter l\u2019heure d\u2019administration des traitements pour optimiser leur efficacit\u00e9 et limiter les effets secondaires.<\/p>\n

Cette ann\u00e9e encore,\u00a0l\u2019immunoth\u00e9rapie<\/a>\u00a0a eu une place particuli\u00e8rement importante au congr\u00e8s annuel de la Soci\u00e9t\u00e9 am\u00e9ricaine d\u2019oncologie (Asco). De nouvelles mol\u00e9cules, de nouveaux traitements permettent d\u2019am\u00e9liorer la vie des malades. Ce lundi soir, avant-dernier jour du congr\u00e8s, une session particuli\u00e8rement int\u00e9ressante sur l\u2019utilisation de l\u2019immunoth\u00e9rapie en vie r\u00e9elle, \u00e9valuant les diff\u00e9rentes strat\u00e9gies d\u2019administration, s\u2019est tenue devant une salle malheureusement un peu clairsem\u00e9e.<\/p>\n

\u00ab\u00a0Il y a un foss\u00e9 quand on passe des essais cliniques \u00e0 l\u2019utilisation des m\u00e9dicaments en vie r\u00e9elle\u00a0\u00bb, explique d\u2019embl\u00e9e l\u2019orateur principal de la session, Timoth\u00e9e Olivier, canc\u00e9rologue aux h\u00f4pitaux universitaires de Gen\u00e8ve. Cela s\u2019explique pour plusieurs raisons. \u00ab\u00a0Le recrutement dans les essais cliniques s\u00e9lectionne des personnes qui ne sont pas repr\u00e9sentatives de la vie r\u00e9elle (en particulier,\u00a0les personnes tr\u00e8s \u00e2g\u00e9es<\/a>, souffrant de comorbidit\u00e9s ou en mauvais \u00e9tat g\u00e9n\u00e9ral sont le plus souvent exclues\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 83% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vente Flash<\/p>\n

4,99\u20ac par mois pendant 12 mois. Sans engagement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"D\u00c9CRYPTAGE – De nombreuses \u00e9tudes pr\u00e9sent\u00e9es lors du congr\u00e8s de canc\u00e9rologie de Chicago ont mis en avant l\u2019int\u00e9r\u00eat…\n","protected":false},"author":2,"featured_media":153047,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-153046","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114628799036758561","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/153046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=153046"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/153046\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/153047"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=153046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=153046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=153046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}